Exelixis Inc 2023 SR
The report highlights Exelixis' progress in oncology innovation, community engagement, and environmental management. Key achievements include the LEED Gold Certification for its Alameda campus building and the expansion of the Inclusiveness Initiative to increase diversity in clinical trials. The company also launched eight employee resource groups and reported that its R&D investment accounted for 55% of total revenues in 2022. Additionally, Exelixis implemented an "Energy Dashboard" to track and optimize energy usage across its facilities.
Company: Exelixis Inc
Sector: Health Care
Country: United States
Year: 2023
Type: SR
Pages: 60
Exelixis Inc
The report highlights Exelixis' progress in oncology innovation, community engagement, and environmental management. Key achievements include the LEED Gold Certification for its Alameda campus building and the expansion of the Inclusiveness Initiative to increase diversity in clinical trials. The company also launched eight employee resource groups and reported that its R&D investment accounted for 55% of total revenues in 2022. Additionally, Exelixis implemented an "Energy Dashboard" to track and optimize energy usage across its facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jul 1, 2022 - Jun 30, 2023
Fiscal Year
2023
Published
Oct 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Women on Board
Women in Management
Employees